These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29537283)
1. Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models. Kang L; Jiang D; Ehlerding EB; Barnhart TE; Ni D; Engle JW; Wang R; Huang P; Xu X; Cai W Mol Pharm; 2018 Apr; 15(4):1627-1634. PubMed ID: 29537283 [TBL] [Abstract][Full Text] [Related]
2. CD38 as a PET Imaging Target in Lung Cancer. Ehlerding EB; England CG; Jiang D; Graves SA; Kang L; Lacognata S; Barnhart TE; Cai W Mol Pharm; 2017 Jul; 14(7):2400-2406. PubMed ID: 28573863 [TBL] [Abstract][Full Text] [Related]
4. ImmunoPET imaging of CD38 in murine lymphoma models using Kang L; Jiang D; England CG; Barnhart TE; Yu B; Rosenkrans ZT; Wang R; Engle JW; Xu X; Huang P; Cai W Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1372-1381. PubMed ID: 29450576 [TBL] [Abstract][Full Text] [Related]
5. ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer. England CG; Kamkaew A; Im HJ; Valdovinos HF; Sun H; Hernandez R; Cho SY; Dunphy EJ; Lee DS; Barnhart TE; Cai W Mol Pharm; 2016 Jun; 13(6):1958-66. PubMed ID: 27054683 [TBL] [Abstract][Full Text] [Related]
6. ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer. Ehlerding EB; England CG; Majewski RL; Valdovinos HF; Jiang D; Liu G; McNeel DG; Nickles RJ; Cai W Mol Pharm; 2017 May; 14(5):1782-1789. PubMed ID: 28388076 [TBL] [Abstract][Full Text] [Related]
7. ImmunoPET imaging of tissue factor expression in pancreatic cancer with Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831 [TBL] [Abstract][Full Text] [Related]
8. Immuno-PET imaging of tumor endothelial marker 8 (TEM8). Kuo F; Histed S; Xu B; Bhadrasetty V; Szajek LP; Williams MR; Wong K; Wu H; Lane K; Coble V; Vasalatiy O; Griffiths GL; Paik CH; Elbuluk O; Szot C; Chaudhary A; St Croix B; Choyke P; Jagoda EM Mol Pharm; 2014 Nov; 11(11):3996-4006. PubMed ID: 24984190 [TBL] [Abstract][Full Text] [Related]
10. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer. England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models. Li C; Yang Q; Chen Z; Qiu Y; Du Y; Wang R; He Q; Yang J; Zhen H; Kang L Mol Pharm; 2022 Oct; 19(10):3521-3529. PubMed ID: 35427142 [TBL] [Abstract][Full Text] [Related]
12. CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin. Chen R; Hou J; Newman E; Kim Y; Donohue C; Liu X; Thomas SH; Forman SJ; Kane SE Mol Cancer Ther; 2015 Jun; 14(6):1376-84. PubMed ID: 25840583 [TBL] [Abstract][Full Text] [Related]
13. Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent. White JM; Kuda-Wedagedara AN; Wicker MN; Spratt DE; Schopperle WM; Heath E; Viola NT Mol Pharm; 2020 Apr; 17(4):1139-1147. PubMed ID: 32069422 [TBL] [Abstract][Full Text] [Related]
14. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer. Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417 [TBL] [Abstract][Full Text] [Related]
15. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors. Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694 [TBL] [Abstract][Full Text] [Related]
16. Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines. Schönberger S; van Beekum C; Götz B; Nettersheim D; Schorle H; Schneider DT; Casati A; Craveiro RB; Calaminus G; Dilloo D J Cell Mol Med; 2018 Jan; 22(1):568-575. PubMed ID: 28941150 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. Hong H; Severin GW; Yang Y; Engle JW; Zhang Y; Barnhart TE; Liu G; Leigh BR; Nickles RJ; Cai W Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):138-48. PubMed ID: 21909753 [TBL] [Abstract][Full Text] [Related]
18. Cysteine-specific Lee JH; Jung KH; Kim M; Lee KH Front Immunol; 2022; 13():1017132. PubMed ID: 36591250 [TBL] [Abstract][Full Text] [Related]
19. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody. Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560 [TBL] [Abstract][Full Text] [Related]
20. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis. Sharma SK; Sevak KK; Monette S; Carlin SD; Knight JC; Wuest FR; Sala E; Zeglis BM; Lewis JS J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]